Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptorum Group Limited - Class A Ordinary Shares (NQ:APM)

2.519 +0.189 (+8.12%)
Streaming Delayed Price Updated: 10:10 AM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptorum Group Limited - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
51 Biggest Movers From Yesterday
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... 
Via Benzinga
SDC Stock Alert: What Has SmileDirectClub Investors Grinning Ear to Ear Today
SmileDirectClub (SDC) stock is soaring higher on Tuesday as investors celebrate a new strategic plan from the oral health company. 
Via InvestorPlace
APM Stock Alert: What Is Going on With Little-Known Aptorum Today?
APM stock is skyrocketing on Tuesday following news of an FDA designation. Does this mean the meme stocks crazy isn't over? 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Sierra Oncology (NASDAQ:SRRA) stock rose 45.6% to $22.58 during Tuesday's pre-market session. The market value of their outstanding shares is at $339.9 million... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Aptorum Group (NASDAQ:APM) stock m... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! It's time to get this week going with a breakdown of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
53 Biggest Movers From Friday
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Mustang Bio (NASDAQ:MBIO) shares ... 
Via Benzinga
34 Stocks Moving In Friday's Mid-Day Session
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91.... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares rose 422% to $9.93 in pre-market trading after gaining around 9% on Thursday. Barfresh Food Group Inc. (... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Aptorum Group Limited (NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company announced it received FDA Orphan Drug designation for... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Aptorum Group (NASDAQ:APM) stock increased by 32.8% to $1.62 during Thursday's regular session. Aptorum Group's stock is trading at a volume of 86.4... 
Via Benzinga
Stocks Roar Back to Life Despite Alarming Jobs Data
Stocks are staging a massive comeback today, with the Dow Jones Industrial Average last seen up 428 points midday. Both the S&P 500 Index and Nasdaq Composite are sporting solid midday gains as well. 
Via Talk Markets
Aptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer
The FDA has granted Orphan Drug Designation to Aptorum Group Limited (NASDAQ: APM) SACT-1, a repurposed small molecule compound for Neuroblastoma. Aptorum... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (... 
Via Benzinga
Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma
From Aptorum Group Limited
Via Business Wire
Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Interview to Air on Bloomberg U.S.
From Aptorum Group Limited
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.